94
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Trigger-oriented HIV testing at Internal Medicine hospital Departments in Northern Italy: an observational study (Fo.C.S. Study)

, , , , , , , , , , , , , , & show all
Pages 838-843 | Received 04 Aug 2015, Accepted 14 Mar 2016, Published online: 11 Aug 2016

References

  • Istituto Superiore di Sanità. Aggiornamento delle nuove diagnosi di infezione da HIV e dei casi di AIDS in Italia al 31 dicembre 2012. Available online at: http://www.iss.it/binary/ccoa/cont/coa_2012_12_novembre_2013_DEFINITIVO.pdf. [last accessed 25 July 2016].
  • Suligoi B, Raimondo M, Fanales-Belasio E, et al. The epidemic of HIV infection and AIDS, promotion of testing and innovative strategies. Ann Ist Super Sanita. 2010;46:15–23.
  • Casari S, Suligoi B, Camoni L, et al. from NU.DI.H. Study Group. Epidemiological and clinical characteristics and behaviors of individuals with newly diagnosed HIV infection: a multicentre study in north Italy. J Prev Med Hyg. 2012;53:190–194.
  • ECDC/WHO Regional Office for Europe: HIV/AIDS surveillance in Europe 2013. Stockholm: European Centre for Disease Prevention and Control; 2014.
  • Antinori A, Coenen T, Costagiola D, et al. Late presentation of HIV infection: a consensus definition. HIV Med. 2011;12:61–64.
  • Longo B, Pezzotti P, Boros S, et al. Increasing proportion of late testers among AIDS cases in Italy, 1996-2002. AIDS Care. 2005;17:834–841.
  • Camoni L, Raimondo M, Regine V, et al. regional representatives of the HIV Surveillance System. Late presenters among persons with a new HIV diagnosis in Italy, 2010-2011. BMC Public Health. 2013;13:281.
  • Hall HI, Halverson J, Wilson DP, et al. Late diagnosis and entry to care after diagnosis of human immunodeficiency virus infection: a country comparison. PLoS One. 2013;8:e77763.
  • Mensforth S, Goodall L, Bodasing N, et al. Late diagnosis among our ageing HIV population: a cohort study. J Int AIDS Soc. 2014;17(Suppl 3):19692.
  • Joint United Nations Programme on HIV/AIDS (UNAIDS). The GAP Report, UNAIDS, 2014. Available online at: http://www.unaids.org/en/resources/documents/2014/20140716_UNAIDS_gap_report [last Accessed 5 January 2016].
  • Holmberg SD, Palella FJ Jr, Lichtenstein KA, et al. The case for earlier treatment of HIV infection. Clin Infect Dis. 2004;39:1699–1704.
  • Antinori A, Johnson M, Moreno S, et al. Report of a European Working Group on late presentation with HIV infection: recommendations and regional variation. Antivir Ther. 2010;15(Suppl 1):31–35.
  • Moreno S, Mocroft A, D’Arminio Monforte A. Medical and societal consequences of late presentation. Antivir Ther. 2010;15(Suppl 1):9–15.
  • Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006;20:1447–1450.
  • Camoni L, Raimondo M, Dorrucci M, et al. and the CARPHA Study Group. Estimating minimum adult HIV Prevalence: a cross-sectional study to assess the characteristics of people living with HIV in Italy. AIDS Res Human Retroviruses. 2015;31:282–287.
  • Mammone A, Pezzotti P, Regine V, et al. How many people are living with undiagnosed HIV infection? An estimate for Italy based on surveillance data. AIDS. 2016;30:1131–1136.
  • Branson BM, Hunter Handsfield H, Lampe M, et al. Centers for Disease Control and Prevention revised recommendations for HIV testing of adults, adolescents and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55:1–17.
  • Shakman BR, Freedberg KA, Weinstein MC, et al. Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adults. Arch Intern Med. 2002;162:2478–2486.
  • Walensky RP, Freedberg KA, Weinstein MC, et al. Cost-effectiveness of HIV testing and treatment in the United States. Clin Infect Dis. 2007;45(Suppl 4):S248–54.
  • Sudarshi D, Pao D, Murphy G, et al. Missed opportunities for diagnosing primary HIV infection. Sex Transm Infect. 2008;84:14–16.
  • Voetsch AC, Heffelfinger JD, Yonek J, et al. HIV screening practices in U.S. hospitals, 2009-2010. Public Health Rep. 2012;127:524–531.
  • Champenois K, Cousien A, Cuzin L, et al. Missed opportunities for HIV testing in newly-HIV-diagnosed patients, a cross sectional study. BMC Infect Dis. 2013;13:200.
  • European Centre for Disease Prevention and Control. HIV testing: increasing uptake and effectiveness in the European Union. Stockholm: ECDC; 2010.
  • Liddicoat RV, Horton NJ, Urban R, et al. Assessing missed opportunities for HIV testing in medical settings. J Gen Intern Med. 2004;19:349–356.
  • Sullivan AK, Raben D, Reekie J, et al. Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study). PLoS One. 2013;8:e52845.
  • Gazzard B, Clumeck N, d’Arminio Monforte A, et al. Indicator disease-guided testing for HIV – the next step for Europe? HIV Med. 2008;9(Suppl 2):34–40.
  • Scognamiglio P, Chiaradia G, De Carli G, et al. from SENDIH Study Group. The potential impact of routine testing of individuals with HIV indicator diseases in order to prevent late HIV diagnosis. BMC Infect Dis. 2013;13:473.
  • Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41:1–19.
  • Centers for Disease Control and Prevention. National Centre of Health Statistics. International Classification of Diseases and related health problems – Tenth Revision (ICD-10). 1999. Available online at: http://www.who.int/classifications/icd/en/. [last accessed 25 July 2016].
  • Raben D, Mocroft A, Rayment M, Mitsura, VM, Hadziosmanovic V, Sthoeger ZM, et al. Auditing HIV testing rates across Europe: results from the HIDES 2 Study. PLoS One. 2015;10:e0140845.
  • Spornraft-Ragaller P, Boashie U, Stephan V, et al. Analysis of risk factors for late presentation in a cohort of HIV-infected patients in Dresden: positive serology for syphilis in MSM is a determinant for earlier HIV diagnosis. Infection. 2013;41:1145–1155.
  • Cohen MS, Chen YQ, McCauley M, et al. For the HPTN 052 Study Team. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493–505.
  • Ministero della salute. Legge 135 - 5 Giugno 1990. Piano degli interventi urgenti per la prevenzione e la lotta contro l’AIDS. Available online at: http://www.salute.gov.it/imgs/C_17_normativa_1654_allegato.pdf. [last accessed 25 July 2016].
  • Zheng MY, Suneja A, Chou AL, Arya M. Physician barriers to successful implementation of US Preventive Services Task Force routine HIV testing recommendations. J Int Assoc Provid AIDS Care. 2014;13:200–205.
  • Infectious Diseases Society of America (IDSA). Available online at: http://www.idsociety.org/ID_Specialist/. [last accessed 25 July 2016].
  • Prosperi MC, Cozzi-Lepri A, Antinori A, Cassola G, Torti C, Ursitti MA, et al. From Icona Foundation Study Group. Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008. HIV Med. 2011;12:174–182.
  • Linee Guida Italiane sull’utilizzo dei farmaci antiretrovirali e sulla gestione diagnostico-clinica delle persone con infezione da HIV-1. 2015. Available online at: http://www.salute.gov.it/imgs/c_17_pubblicazioni_2442_allegato.pdf. [last accessed 25 July 2016].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.